OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Prostatic cancers: understanding their molecular pathology and the 2016 WHO classification
Kentaro Inamura
Oncotarget (2018) Vol. 9, Iss. 18, pp. 14723-14737
Open Access | Times Cited: 45
Kentaro Inamura
Oncotarget (2018) Vol. 9, Iss. 18, pp. 14723-14737
Open Access | Times Cited: 45
Showing 1-25 of 45 citing articles:
A Tale of Two Cancers: A Current Concise Overview of Breast and Prostate Cancer
Franklyn De Silva, Jane Alcorn
Cancers (2022) Vol. 14, Iss. 12, pp. 2954-2954
Open Access | Times Cited: 37
Franklyn De Silva, Jane Alcorn
Cancers (2022) Vol. 14, Iss. 12, pp. 2954-2954
Open Access | Times Cited: 37
A systematic review of primary large cell neuroendocrine carcinoma of the prostate
Ngan Luu-Thuy Nguyen, Ronald Dean Franz, Omar J. Mohammed, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 5
Ngan Luu-Thuy Nguyen, Ronald Dean Franz, Omar J. Mohammed, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 5
Cellular and Molecular Progression of Prostate Cancer: Models for Basic and Preclinical Research
Sirin Saranyutanon, Sachin Kumar Deshmukh, Santanu Dasgupta, et al.
Cancers (2020) Vol. 12, Iss. 9, pp. 2651-2651
Open Access | Times Cited: 37
Sirin Saranyutanon, Sachin Kumar Deshmukh, Santanu Dasgupta, et al.
Cancers (2020) Vol. 12, Iss. 9, pp. 2651-2651
Open Access | Times Cited: 37
Inflammation in Prostate Cancer: Exploring the Promising Role of Phenolic Compounds as an Innovative Therapeutic Approach
Raquel Fernandes, Cátia Costa, Rúben Fernandes, et al.
Biomedicines (2023) Vol. 11, Iss. 12, pp. 3140-3140
Open Access | Times Cited: 10
Raquel Fernandes, Cátia Costa, Rúben Fernandes, et al.
Biomedicines (2023) Vol. 11, Iss. 12, pp. 3140-3140
Open Access | Times Cited: 10
Feasibility of Indirect Treatment Comparisons Between Niraparib Plus Abiraterone Acetate and Other First-Line Poly ADP-Ribose Polymerase Inhibitor Treatment Regimens for Patients with BRCA1/2 Mutation-Positive Metastatic Castration-Resistant Prostate Cancer
Maria De Santis, Sara Martínez Breijo, Paul Robinson, et al.
Advances in Therapy (2024) Vol. 41, Iss. 8, pp. 3039-3058
Open Access | Times Cited: 3
Maria De Santis, Sara Martínez Breijo, Paul Robinson, et al.
Advances in Therapy (2024) Vol. 41, Iss. 8, pp. 3039-3058
Open Access | Times Cited: 3
Prostate cancer and inflammation: A new molecular imaging challenge in the era of personalized medicine
Orazio Schillaci, Manuel Scimeca, Donata Trivigno, et al.
Nuclear Medicine and Biology (2019) Vol. 68-69, pp. 66-79
Closed Access | Times Cited: 23
Orazio Schillaci, Manuel Scimeca, Donata Trivigno, et al.
Nuclear Medicine and Biology (2019) Vol. 68-69, pp. 66-79
Closed Access | Times Cited: 23
Development of a novel, clinically relevant anoikis-related gene signature to forecast prognosis in patients with prostate cancer
Xiaolin Liu, Kunming Wang
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 7
Xiaolin Liu, Kunming Wang
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 7
Targeting Nodal and Cripto-1: Perspectives Inside Dual Potential Theranostic Cancer Biomarkers
Annamaria Sandomenico, Menotti Ruvo
Current Medicinal Chemistry (2018) Vol. 26, Iss. 11, pp. 1994-2050
Closed Access | Times Cited: 20
Annamaria Sandomenico, Menotti Ruvo
Current Medicinal Chemistry (2018) Vol. 26, Iss. 11, pp. 1994-2050
Closed Access | Times Cited: 20
Hormonal Therapy for Prostate Cancer
Irina A. Vasilevskaya, Matthew J. Schiewer, Karen E. Knudsen
Oxford University Press eBooks (2022), pp. 1790-1804
Closed Access | Times Cited: 11
Irina A. Vasilevskaya, Matthew J. Schiewer, Karen E. Knudsen
Oxford University Press eBooks (2022), pp. 1790-1804
Closed Access | Times Cited: 11
Prostate cancer-derived holoclones: a novel and effective model for evaluating cancer stemness
Louise Flynn, Martin P. Barr, Anne‐Marie Baird, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 13
Louise Flynn, Martin P. Barr, Anne‐Marie Baird, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 13
Biopolymer and Biomaterial Conjugated Iron Oxide Nanomaterials as Prostate Cancer Theranostic Agents: A Comprehensive Review
Md. Abu Rayhan, Md. Sakib Hossen, Mahruba Sultana Niloy, et al.
Symmetry (2021) Vol. 13, Iss. 6, pp. 974-974
Open Access | Times Cited: 11
Md. Abu Rayhan, Md. Sakib Hossen, Mahruba Sultana Niloy, et al.
Symmetry (2021) Vol. 13, Iss. 6, pp. 974-974
Open Access | Times Cited: 11
A Case of Prostatic Signet-Ring Cell-like Carcinoma with Pagetoid Spread and Intraductal Carcinoma and Long-Term Survival: PD-L1 and Mismatch Repair System Proteins (MMR) Immunohistochemical Evaluation with Systematic Literature Review
Nektarios Koufopoulos, Argyro-Ioanna Ieronimaki, Andriani Zacharatou, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 6, pp. 1016-1016
Open Access | Times Cited: 4
Nektarios Koufopoulos, Argyro-Ioanna Ieronimaki, Andriani Zacharatou, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 6, pp. 1016-1016
Open Access | Times Cited: 4
Ductal Adenocarcinoma of the Prostate with Novel Genetic Alterations Characterized by Next-Generation Sequencing
Alexandra Zara Rozalen, José Manuel Martín, Rithika Rajendran, et al.
Current Oncology (2024) Vol. 31, Iss. 3, pp. 1556-1561
Open Access | Times Cited: 1
Alexandra Zara Rozalen, José Manuel Martín, Rithika Rajendran, et al.
Current Oncology (2024) Vol. 31, Iss. 3, pp. 1556-1561
Open Access | Times Cited: 1
Expression of GP88 (Progranulin) Protein Is an Independent Prognostic Factor in Prostate Cancer Patients
Amer Abdulrahman, Markus Eckstein, Rudolf Jung, et al.
Cancers (2019) Vol. 11, Iss. 12, pp. 2029-2029
Open Access | Times Cited: 10
Amer Abdulrahman, Markus Eckstein, Rudolf Jung, et al.
Cancers (2019) Vol. 11, Iss. 12, pp. 2029-2029
Open Access | Times Cited: 10
Expression of AR-V7 (Androgen Receptor Variant 7) Protein in Granular Cytoplasmic Structures Is an Independent Prognostic Factor in Prostate Cancer Patients
Paul König, Markus Eckstein, Rudolf Jung, et al.
Cancers (2020) Vol. 12, Iss. 9, pp. 2639-2639
Open Access | Times Cited: 8
Paul König, Markus Eckstein, Rudolf Jung, et al.
Cancers (2020) Vol. 12, Iss. 9, pp. 2639-2639
Open Access | Times Cited: 8
Locally invasive, castrate-resistant prostate cancer in a Pten/Trp53 double knockout mouse model of prostate cancer monitored with non-invasive bioluminescent imaging
Courtney Yong, Devon L. Moose, Nadine Bannick, et al.
PLoS ONE (2020) Vol. 15, Iss. 9, pp. e0232807-e0232807
Open Access | Times Cited: 7
Courtney Yong, Devon L. Moose, Nadine Bannick, et al.
PLoS ONE (2020) Vol. 15, Iss. 9, pp. e0232807-e0232807
Open Access | Times Cited: 7
Deregulation cascades in carcinogenesis
Roberto Herrero, Jean‐Pierre Gomez, Gabriel Gil, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Roberto Herrero, Jean‐Pierre Gomez, Gabriel Gil, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Cell-Free DNA Variant Sequencing Using Plasma and AR-V7 Testing of Circulating Tumor Cells in Prostate Cancer Patients
Verena Lieb, Amer Abdulrahman, Katrin Weigelt, et al.
Cells (2021) Vol. 10, Iss. 11, pp. 3223-3223
Open Access | Times Cited: 4
Verena Lieb, Amer Abdulrahman, Katrin Weigelt, et al.
Cells (2021) Vol. 10, Iss. 11, pp. 3223-3223
Open Access | Times Cited: 4
Deregulation cascades in carcinogenesis
Roberto Herrero, Jean‐Pierre Gomez, Gabriel Gil, et al.
Research Square (Research Square) (2024)
Open Access
Roberto Herrero, Jean‐Pierre Gomez, Gabriel Gil, et al.
Research Square (Research Square) (2024)
Open Access
Clinicopathologic patterns and survival patterns among prostate carcinosarcoma patients in the United States
Asad Ullah, Naema Daino, Abdul Qahar Khan Yasinzai, et al.
Canadian Urological Association Journal (2024) Vol. 18, Iss. 11
Open Access
Asad Ullah, Naema Daino, Abdul Qahar Khan Yasinzai, et al.
Canadian Urological Association Journal (2024) Vol. 18, Iss. 11
Open Access
Neoplasms of the Prostate
David G. Bostwick, Liang Cheng
Elsevier eBooks (2020), pp. 415-525.e42
Closed Access | Times Cited: 3
David G. Bostwick, Liang Cheng
Elsevier eBooks (2020), pp. 415-525.e42
Closed Access | Times Cited: 3
Molecular evaluation of human papillomavirus as an oncogenic biomarker in prostate cancer
Soukayna Alaoui Sosse, Abdelilah Laraqui, Mohammed Mrabti, et al.
Molecular Biology Reports (2023) Vol. 50, Iss. 7, pp. 5719-5724
Closed Access | Times Cited: 1
Soukayna Alaoui Sosse, Abdelilah Laraqui, Mohammed Mrabti, et al.
Molecular Biology Reports (2023) Vol. 50, Iss. 7, pp. 5719-5724
Closed Access | Times Cited: 1
Quality of Care for Prostate Cancer in Kashmir, India: A Real-World Study
Omar Akhtar, Sayed Abdur R Andrabi, Pakeezah S Bhat, et al.
Cureus (2023)
Open Access | Times Cited: 1
Omar Akhtar, Sayed Abdur R Andrabi, Pakeezah S Bhat, et al.
Cureus (2023)
Open Access | Times Cited: 1
Primary prostatic signet ring cell carcinoma in elderly with obstructive uropathy: a case report
Simran Sidhu, Mohamad Fairuz Mohd Sharin, Khairul Asri Mohd Ghani, et al.
African Journal of Urology (2022) Vol. 28, Iss. 1
Open Access | Times Cited: 2
Simran Sidhu, Mohamad Fairuz Mohd Sharin, Khairul Asri Mohd Ghani, et al.
African Journal of Urology (2022) Vol. 28, Iss. 1
Open Access | Times Cited: 2
